Evolvere Biosciences Analysis: $500K Raised
What is Evolvere Biosciences?
Evolvere Biosciences develops innovative immunology therapies to meet unmet medical needs.
Employees
3
Founded
2021
Product Features & Capabilities
- next-generation antibiotics, precision targeting of pathogenic bacteria, combating antimicrobial resistance, rapid generation of antibacterials, dual revenue from therapeutic assets and licensed AI tools
How much Evolvere Biosciences raised
Pre-Seed - $500,000
September 25, 2024Lead Investor: Y Combinator
Who are the founders of Evolvere Biosciences
Market Focus
Evolvere Biosciences primarily focuses on the biotechnology industry, specifically developing innovative therapies in the field of immunology to address unmet medical needs.
Competitors Overview
Evolvere Biosciences has several notable competitors in the health and wellness biosciences market. Key competitors include:
- BioNTech: Known for its innovative mRNA technology, BioNTech focuses on developing personalized cancer therapies and vaccines. Their advantage lies in their advanced r
Investors
- Cleo Capital
- Y Combinator
- BioEscalator
- Saïd Business School
See something that needs updating? Suggest edits to this profile.